Last reviewed · How we verify
Wide-spectrum nutritional supplement — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Wide-spectrum nutritional supplement (Wide-spectrum nutritional supplement) — Rossignol Medical Center.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Wide-spectrum nutritional supplement TARGET | Wide-spectrum nutritional supplement | Rossignol Medical Center | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Wide-spectrum nutritional supplement CI watch — RSS
- Wide-spectrum nutritional supplement CI watch — Atom
- Wide-spectrum nutritional supplement CI watch — JSON
- Wide-spectrum nutritional supplement alone — RSS
Cite this brief
Drug Landscape (2026). Wide-spectrum nutritional supplement — Competitive Intelligence Brief. https://druglandscape.com/ci/wide-spectrum-nutritional-supplement. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing